Articles published in Journal of Pharmacovigilance have been cited by esteemed scholars and scientists all around the world. Journal of Pharmacovigilance has got h-index 24, which means every article in Journal of Pharmacovigilance has got 24 average citations.
Following are the list of articles that have cited the articles published in Journal of Pharmacovigilance.
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Year wise published articles |
61 | 61 | 17 | 5 | 26 |
Year wise citations received |
237 | 311 | 270 | 254 | 222 |
Journal total citations count | 2103 |
Journal Impact Factor | 1.71 |
Journal 5 years Impact Factor | 1.79 |
Journal CiteScore | 12.14 |
Journal h-index | 24 |
Predicting and understanding comprehensive drug-drug interactions via semi-nonnegative matrix factorization
A Large-Scale CNN Ensemble for Medication Safety Analysis
Dependency-based long short term memory network for drug-drug interaction extraction
Drug-drug interaction extraction from biomedical texts using long short-term memory network
Application of Novel Genotyping Microarray Technologies in Cancer Research
A Survey of Network-Based Modelling and Intelligent Data Mining of Social Media for Improving Care
Adverse Drug Event Information Extraction from Medical Narratives using Ensemble Learning & Deep Learning
Novel Antitumor Benefit of Metformin: Beyond Glycemic Control
Real-world data-based adverse drug reactions detection from the Korea Adverse Event Reporting System databases with electronic health records-based detection algorithm
The pivotal relation between glucagon-like peptides, NF?B and inflammatory bowel disease
Management of Type 2 Diabetes: Current Strategies, Unfocussed Aspects, Challenges, and Alternatives
Multi-layered Learning for Information Extraction from Adverse Drug Event Narratives
Cardiovascular outcome trials in type 2 diabetes: A critical analysis
Combining GLP-1 Receptor Agonists and Basal Insulin in Older Adults with Type 2 Diabetes: Focus on Lixisenatide and Insulin Glargine
One Size Does Not Fit All: An Ensemble Approach Towards Information Extraction from Adverse Drug Event Narratives
Incident cancer risk in dipeptidyl peptidase-4 inhibitor-treated patients with type 2 diabetes mellitus
The anti-diabetic drug exenatide, a glucagon-like peptide-1 receptor agonist, counteracts hepatocarcinogenesis through cAMP–PKA–EGFR–STAT3 axis
Adverse Effects of GLP-1 Receptor Agonists
Antidiabetic Activity and Pharmacodynamic Interaction of Combined Administration of Ethanolic Stem Bark Extract of Enantia Chlorantha and Lisinopril in Type 2 Diabetic Rats
Risk of Hypoglycemia After Concomitant Use of Antidiabetic, Antihypertensive, and Antihyperlipidemic Medications: A Database Study